Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1 1

Status

Completed 60Unknown 11Terminated 8Withdrawn 3Recruiting 3Active not recruiting 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1

Conditions

Sarcoma 1Neoplasms 1Cancer Pain 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Fentanyl × Clear all
NCT07276867 2025-12-11

Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

National Cancer Institute, Egypt

Phase NA Recruiting
58 enrolled
Sarcoma

Sarcoma

NCT06953453 2025-09-25

A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors

Lee's Pharmaceutical Limited

Phase 1 Recruiting
100 enrolled
Tumor-Agnostic

Neoplasms

NCT06498037 2024-07-12

FERRARI

Erasmus Medical Center

Phase 4 Recruiting
45 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡